Open Lending Reports Fourth Quarter and Fiscal Year 2020 Financial Results
“The fourth quarter was a great end to a very productive year for
Three Months Ended
- The Company facilitated 26,822 certified loans during the fourth quarter of 2020, compared to 22,559 certified loans in the fourth quarter of 2019
- Total revenue was
$39.6 million , compared to$26.1 million in the fourth quarter of 2019 - Gross profit was
$36.7 million , compared to$23.8 million in fourth quarter of 2019 - GAAP net income was
$15.2 million , compared to$17.4 million in fourth quarter of 2019 - Adjusted EBITDA was
$24.8 million , compared to$18.1 million in the fourth quarter of 2019
Twelve Months Ended
- The Company facilitated 94,226 certified loans, compared to 78,434 certified loans in 2019
- Total revenue was
$108.9 million , compared to$92.8 million in 2019 - Gross profit was
$99.1 million , compared to$85.0 million in 2019 - GAAP net loss was
$(97.6) million , compared to GAAP net income of$62.5 million in 2019. The GAAP net loss was primarily attributable to$(131.9) million in change in estimated fair value of contingent consideration shares awarded as part of the business combination withNebula Acquisition Corporation (“Nebula”) onJune 10, 2020 . - Adjusted EBITDA was
$69.5 million , compared to$64.9 million in 2019
Adjusted EBITDA is a non-GAAP financial measure. Reconciliations of this non-GAAP financial measure to its most directly comparable GAAP financial measure are provided in the financial tables included at the end of this press release. An explanation of this measure and how it is calculated is also included under the heading “Non-GAAP Financial Measures.”
2021 Outlook
Based on the fourth quarter results and trends into 2021, the Company is reaffirming its previously issued guidance of the following:
Full Year 2021 Outlook | ||
Total Certified Loans | 161,000 - 206,000 | |
Total Revenue | ||
Adjusted EBITDA | ||
Adjusted Operating Cash Flow (a) |
- Adjusted Operating Cash Flow is defined as Adjusted EBITDA, minus CAPEX, plus or minus change in contract assets.
The guidance provided above includes forward-looking statements within the meaning of
Conference Call
About
Forward-Looking Statements
This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995, including statements related to market trends, the anticipated impact of the recent novel coronavirus (COVID-19) pandemic on factors impacting the Company’s business, the Company’s new lender pipeline, consumer behavior and demand for automotive loans, as well as future financial performance under the heading “2021 Outlook” above. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements are based on various assumptions and on the current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the Company’s control. These forward-looking statements are subject to a number of risks and uncertainties, including general economic, political and business conditions; the potential effects of COVID-19; applicable taxes, inflation, interest rates and the regulatory environment; the outcome of judicial proceedings to which
Non-GAAP Financial Measures
Included in this press release is financial information that has not been prepared in accordance with GAAP. The Company uses Adjusted EBITDA, a non-GAAP financial measure, internally in analyzing our financial results and believe it is useful to investors, as a supplement to GAAP measures, in evaluating our ongoing operational performance. The Company believes that the use of this non-GAAP financial measure provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial results with other companies in our industry, many of which present similar non-GAAP financial measures to investors.
Adjusted EBITDA is a non-GAAP financial measure used by management to evaluate its operating performance, generate future operating plans, and make strategic decisions, including those relating to operating expenses and the allocation of internal resources. Accordingly, the Company believes these measures provide useful information to investors and others in understanding and evaluating its operating results in the same manner as its management and board of directors. In addition, they provide useful measures for period-to-period comparisons of our business, as they remove the effect of certain non-cash items and certain non-recurring variable charges. Adjusted EBITDA is defined as GAAP net income (loss) excluding interest expense, income taxes, depreciation and amortization expense, share-based compensation expense, change in fair value of contingent consideration, change in measurement – tax receivable agreement and transaction bonuses as a result of the Business Combination. Adjusted EBITDA margin is defined as Adjusted EBITDA expressed as a percentage of total revenue.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of Adjusted EBITDA to its most directly comparable GAAP financial measure provided in the financial statement tables included below in this press release.
Contact:
ICR for
Investors
openlending@icrinc.com
Consolidated Balance Sheets (In thousands, except per share data) |
||||||||
2020 (Unaudited) |
2019 |
|||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 101,513 | $ | 7,676 | ||||
Restricted cash | 2,635 | 2,222 | ||||||
Accounts receivable | 4,352 | 3,767 | ||||||
Current contract assets | 50,386 | 29,782 | ||||||
Prepaid expenses | 1,873 | 479 | ||||||
Other current assets | 2,018 | 205 | ||||||
Deferred transaction costs | — | 1,081 | ||||||
Total current assets | 162,777 | 45,212 | ||||||
Property and equipment, net | 1,201 | 299 | ||||||
Operating lease right-of-use assets, net | 5,733 | — | ||||||
Non-current contract assets | 38,956 | 33,169 | ||||||
Deferred tax asset, net | 85,218 | — | ||||||
Other non-current assets | 124 | 506 | ||||||
Total assets | $ | 294,009 | $ | 79,186 | ||||
Liabilities and stockholders’ equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | 3,442 | 1,337 | ||||||
Accrued expenses | 3,033 | 2,006 | ||||||
Income tax payable | 1,640 | — | ||||||
Current notes payable | 4,888 | 2,484 | ||||||
Other current liabilities | 4,005 | 2,366 | ||||||
Total current liabilities | 17,008 | 8,193 | ||||||
Non-current notes payable, net of unamortized debt issuance costs | 152,859 | 829 | ||||||
Non-current operating lease liabilities | 5,138 | — | ||||||
Other non-current liabilities | 92,382 | — | ||||||
Total liabilities | $ | 267,387 | $ | 9,022 | ||||
Commitments and contingencies | ||||||||
Redeemable convertible Series C preferred units, 0 and 14,278,603 units issued and outstanding as of |
— | 304,943 | ||||||
Stockholders’ equity (deficit) | ||||||||
Preferred stock, |
— | — | ||||||
Common stock, |
1,282 | 376 | ||||||
Additional paid-in capital | 491,246 | 7,626 | ||||||
Accumulated deficit | (428,406 | ) | (242,781 | ) | ||||
(37,500 | ) | — | ||||||
Total stockholders’ equity (deficit) | 26,622 | (234,779 | ) | |||||
Total liabilities and stockholders’ equity (deficit) | $ | 294,009 | $ | 79,186 |
Consolidated Statements of Operations and Comprehensive Income (Loss) (In thousands, except per share data) |
|||||||||||||||
Three Months Ended |
Year Ended |
||||||||||||||
2020 (Unaudited) |
2019 |
2020 (Unaudited) |
2019 |
||||||||||||
Revenue | |||||||||||||||
Program fees | $ | 12,403 | $ | 10,260 | $ | 43,995 | $ | 36,667 | |||||||
Profit share | 25,910 | 14,949 | 60,392 | 53,038 | |||||||||||
Claims administration service fees | 1,320 | 867 | 4,505 | 3,142 | |||||||||||
Total revenue | 39,633 | 26,076 | 108,892 | 92,847 | |||||||||||
Cost of services | 2,968 | 2,289 | 9,786 | 7,806 | |||||||||||
Gross profit | 36,665 | 23,787 | 99,106 | 85,041 | |||||||||||
Operating expenses | |||||||||||||||
General and administrative | 9,351 | 4,104 | 32,584 | 13,774 | |||||||||||
Selling and marketing | 2,350 | 2,027 | 7,841 | 7,482 | |||||||||||
Research and development | 678 | 301 | 1,964 | 1,170 | |||||||||||
Operating income | 24,286 | 17,355 | 56,717 | 62,615 | |||||||||||
Change in fair value of contingent consideration | — | — | (131,932 | ) | — | ||||||||||
Interest expense | (3,621 | ) | (84 | ) | (11,601 | ) | (322 | ) | |||||||
Interest income | 105 | 9 | 202 | 24 | |||||||||||
Other income (expense) | (4,380 | ) | 188 | (4,377 | ) | 197 | |||||||||
Income (loss) before income taxes | 16,390 | 17,468 | (90,991 | ) | 62,514 | ||||||||||
Provision (benefit) for income taxes | 1,188 | 28 | 6,573 | (30 | ) | ||||||||||
Net income (loss) and comprehensive income (loss) | $ | 15,202 | $ | 17,440 | $ | (97,564 | ) | $ | 62,544 | ||||||
Preferred distribution to redeemable convertible Series C preferred units | — | (3,623 | ) | (40,689 | ) | (11,058 | ) | ||||||||
Accretion to redemption value of redeemable convertible Series C preferred units | — | (58,600 | ) | 47,538 | (163,425 | ) | |||||||||
Net income (loss) attributable to common stockholders | $ | 15,202 | $ | (44,783 | ) | $ | (90,715 | ) | $ | (111,939 | ) | ||||
Net income (loss) and comprehensive income (loss) per common share | |||||||||||||||
Basic | 0.12 | (1.19 | ) | (1.09 | ) | (2.97 | ) | ||||||||
Diluted | 0.12 | (1.19 | ) | (1.09 | ) | (2.97 | ) | ||||||||
Weighted average common shares outstanding | |||||||||||||||
Basic | 127,823,098 | 37,631,052 | 82,908,772 | 37,631,052 | |||||||||||
Diluted | 127,911,031 | 37,631,052 | 82,908,772 | 37,631,052 |
Consolidated Statements of Cash Flows (In thousands) |
||||||||
Year Ended |
||||||||
2020 (Unaudited) |
2019 |
|||||||
Cash flows from operating activities | ||||||||
Net income (loss) | $ | (97,564 | ) | $ | 62,544 | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
Share-based compensation | 2,828 | 1,984 | ||||||
Depreciation and amortization | 1,768 | 105 | ||||||
Change in fair value of contingent consideration | 131,932 | — | ||||||
Deferred income taxes | 4,734 | — | ||||||
Non-cash interest expense | — | 92 | ||||||
Changes in assets & liabilities: | ||||||||
Accounts receivable | (585 | ) | (1,829 | ) | ||||
Unbilled revenue | — | — | ||||||
Contract assets | (26,391 | ) | (21,714 | ) | ||||
Operating lease right-of-use assets | (548 | ) | — | |||||
Prepaid expenses | (313 | ) | (830 | ) | ||||
Other current and non-current assets | (1,431 | ) | (481 | ) | ||||
Accounts payable | 2,105 | 583 | ||||||
Accrued expenses | 1,027 | 896 | ||||||
Income tax payable | 1,640 | — | ||||||
Operating lease liabilities | (280 | ) | — | |||||
Other current and noncurrent liabilities | 5,718 | 412 | ||||||
Net cash provided by operating activities | 24,640 | 41,762 | ||||||
Cash flows from investing activities | ||||||||
Purchase of property and equipment | (1,196 | ) | (99 | ) | ||||
Net cash used in investing activities | (1,196 | ) | (99 | ) | ||||
Cash flows from financing activities | ||||||||
Repayments of notes payable | (6,521 | ) | (2,500 | ) | ||||
Proceeds from issuance of long-term debt | 170,000 | — | ||||||
Payment on debt issuance cost | (10,061 | ) | — | |||||
Distributions to |
(135,598 | ) | (42,401 | ) | ||||
Proceeds from stock warrant exercises | 105,349 | — | ||||||
Share repurchase | (37,500 | ) | — | |||||
Recapitalization transaction, net of transaction costs | (14,863 | ) | — | |||||
Net cash provided by (used in) financing activities | 70,806 | (44,901 | ) | |||||
Net change in cash and cash equivalents and restricted cash | 94,250 | (3,238 | ) | |||||
Cash and cash equivalents and restricted cash at the beginning of the year | 9,898 | 13,136 | ||||||
Cash and cash equivalents and restricted cash at the end of the year | $ | 104,148 | $ | 9,898 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Interest paid | $ | 10,444 | $ | 320 | ||||
Income tax paid (refunded), net | 144 | (40 | ) | |||||
Right of use assets obtained in exchange for lease obligations | 5,362 | — | ||||||
The following presents the classification of cash, cash equivalents and restricted cash within the consolidated balance sheets: | ||||||||
Cash and cash equivalents | $ | 101,513 | $ | 7,676 | ||||
Restricted cash | 2,635 | 2,222 | ||||||
Total | $ | 104,148 | $ | 9,898 | ||||
Non-cash investing and financing: | ||||||||
Change in fair value of redeemable convertible Series C preferred units | $ | (47,538 | ) | $ | 163,425 | |||
Conversion of preferred stock to common stock | 257,406 | — | ||||||
Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands) |
||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||
2020 (Unaudited) |
2019 |
2020 (Unaudited) |
2019 |
|||||||||||||
GAAP net income (loss) | $ | 15,202 | $ | 17,440 | $ | (97,564 | ) | $ | 62,544 | |||||||
Non-GAAP adjustments: | ||||||||||||||||
Change in fair value of contingent consideration (1) | — | — | 131,932 | — | ||||||||||||
Transaction bonuses (2) | — | — | 9,112 | — | ||||||||||||
Change in measurement – Tax Receivable Agreement (3) | 4,292 | — | 4,292 | — | ||||||||||||
Interest expense | 3,621 | 84 | 11,601 | 322 | ||||||||||||
Provision (benefit) for income taxes | 1,188 | 28 | 6,573 | (30 | ) | |||||||||||
Depreciation and amortization expense | 346 | 27 | 752 | 105 | ||||||||||||
Share-based compensation (4) | 152 | 487 | 2,828 | 1,984 | ||||||||||||
Total adjustments | 9,599 | 626 | 167,090 | 2,381 | ||||||||||||
Adjusted EBITDA | 24,801 | 18,066 | 69,526 | 64,925 | ||||||||||||
Total net revenue | $ | 39,633 | $ | 26,076 | $ | 108,892 | $ | 92,847 | ||||||||
Adjusted EBITDA margin | 62.6 | % | 69.3 | % | 63.8 | % | 69.9 | % |
Notes:
(1) | Reflects non-cash charges for the change in the estimated fair value of contingent consideration shares from |
|
(2) | Reflects transaction bonuses awarded to key employees and directors in connection with the business combination with Nebula. | |
(3) | Reflects non-cash charges due to changes in the measurement of our Tax Receivable Agreement liability as a result of changes in our blended state tax rate. | |
(4) | Principally represents non-cash charges associated with the Class B Unit Incentive Plan of |
Source: Open Lending Corporation